• S-Adenosylmethionine in Methylation Assays: Applied Protocol

  2026-05-25

  S-Adenosylmethionine (Ademetionine) is a critical methyl donor powering both basic and translational research in methylation biology, neuropsychiatric modeling, and CNS drug screening. This article delivers stepwise workflow enhancements, troubleshooting strategies, and actionable insights for optimizing methylation reactions using APExBIO’s high-purity SAM.

• Betulinic Acid Mitigates Cyclophosphamide-Induced Liver Inju

  2026-05-25

  This study demonstrates that betulinic acid (BA) significantly reduces cyclophosphamide-induced hepatic oxidative stress and apoptosis in mice by activating the NRF2 pathway and inhibiting the MAPK/ERK-mediated mitochondrial apoptotic pathway. The findings highlight a mechanistic link between ERK pathway inhibition and hepatoprotection, providing a rationale for utilizing ERK-targeted tools in preclinical liver injury models.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Applied

  2026-05-24

  Chlorpromazine HCl is a versatile dopamine receptor antagonist that bridges neuropharmacology with infection biology, offering unique mechanistic leverage in both fields. Its dual capacity for receptor inhibition and endocytosis blockade enables advanced experimental designs and reproducible results across psychotic disorder models and host-pathogen interaction studies.

• CD44-Mediated Metabolic Rewiring in IDH-Mutant Leukemia

  2026-05-23

  This study uncovers a critical dependency of IDH-mutant leukemia cells on CD44-driven metabolic rewiring, which sustains NADPH generation and pathological 2-hydroxyglutarate accumulation. By elucidating this mechanism, the research highlights a new therapeutic vulnerability and suggests that dual targeting of mutant IDH and CD44 may overcome resistance in acute myeloid leukemia.

• Pomalidomide (CC-4047): Integrating Genomics in Myeloma Rese

  2026-05-22

  Explore how Pomalidomide (CC-4047) advances hematological malignancy research by aligning molecular mechanisms with cutting-edge genomic insights. This article uniquely connects the compound’s immunomodulatory action to practical assay design in multiple myeloma.

• U0126-EtOH: MEK1/2 Inhibitor Workflows for MAPK/ERK Research

  2026-05-22

  U0126-EtOH from APExBIO elevates MAPK/ERK signaling studies with unmatched selectivity, reliability, and practical versatility. This article delivers actionable protocols, troubleshooting tips, and insights for neuroprotection, inflammation, and mechanistic exploration.

• Spatially Patterned Kidney Assembloids Enable High-Fidelity

  2026-05-21

  Huang et al. introduce spatially patterned human kidney progenitor assembloids (hKPAs) that recapitulate nephron self-assembly and advanced tissue architecture, overcoming critical limitations of prior kidney organoid models. These assembloids provide a robust, physiologically relevant platform for disease modeling and regenerative nephrology research.

• Lisinopril Dihydrate in Cardiovascular Research: Protocols &

  2026-05-21

  Lisinopril dihydrate offers unmatched selectivity and reproducibility for modeling hypertension, heart failure, and nephropathy in translational research. This guide details robust experimental workflows, troubleshooting strategies, and new insights from comparative peptidase inhibition studies—bridging mechanistic rigor with practical lab execution.

• GSK621: AMPK Agonist Workflows for AML and Immunometabolic R

  2026-05-20

  GSK621 enables precise AMPK activation, unlocking robust metabolic and immunometabolic assay workflows in acute myeloid leukemia and tumor microenvironment research. Its superior potency and reproducibility offer clear advantages for apoptosis and autophagy studies. Learn protocol refinements and troubleshooting strategies that maximize GSK621’s impact, as informed by the latest immunometabolic findings.

• Caspase-8 Fluorometric Assay Kit: Innovations in Apoptosis a

  2026-05-20

  Explore the Caspase-8 Fluorometric Assay Kit for advanced cysteine-dependent aspartate-directed protease detection. This in-depth guide reveals new mechanistic insights and experimental protocols for apoptosis and pyroptosis studies.

• Balanced Self-Renewal and Differentiation in Human Intestina

  2026-05-19

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using a combination of small molecule pathway modulators. The approach enhances cellular diversity and proliferative capacity within a single culture condition, addressing longstanding limitations in organoid modeling for developmental and disease research.

• APEX2’s Role in TERT Expression and Telomerase Regulation in

  2026-05-19

  This study uncovers a novel role for APEX2 in regulating efficient TERT gene expression in human embryonic stem cells, revealing mechanistic links between DNA repair and telomerase activity. The findings deepen our understanding of stem cell maintenance and highlight new avenues for therapeutic modulation in aging and cancer.

• Ibrexafungerp (MK 3118): Applied Workflows for Antifungal In

  2026-05-18

  Ibrexafungerp (MK 3118) introduces a new era of antifungal research, uniquely targeting resistant Candida with oral dosing and limited cross-resistance. Discover how this triterpenoid empowers translational and experimental workflows, especially in tackling echinocandin-resistant infections.

• Clozapine in Schizophrenia Research: Mechanisms and Experime

  2026-05-18

  Explore the multifaceted role of Clozapine, an atypical antipsychotic medication, in schizophrenia research. This article offers a mechanistic deep dive and protocol guidance, revealing how ERK1/2 signaling and receptor specificity inform innovative experimental strategies.

• EV-Transferred ACLY Drives TAM-Mediated Immune Suppression i

  2026-05-17

  The reference study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles containing ATP-citrate lyase (ACLY), which are taken up by monocytes and drive their differentiation into immunosuppressive tumor-associated macrophages (TAMs). This work identifies a novel, EV-mediated metabolic mechanism for immune suppression in HCC, highlighting new therapeutic strategies targeting TAMs.

16555 records 1/1104 page Next 12345 下5页 Last page